1-26045188-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001004434.3(SLC30A2):c.80G>A(p.Gly27Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000319 in 1,612,338 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004434.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC30A2 | NM_001004434.3 | c.80G>A | p.Gly27Glu | missense_variant | 2/8 | ENST00000374276.4 | |
SLC30A2 | NM_032513.5 | c.80G>A | p.Gly27Glu | missense_variant | 2/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC30A2 | ENST00000374276.4 | c.80G>A | p.Gly27Glu | missense_variant | 2/8 | 1 | NM_001004434.3 | P1 | |
SLC30A2 | ENST00000374278.7 | c.80G>A | p.Gly27Glu | missense_variant | 2/7 | 1 | |||
SLC30A2 | ENST00000498060.1 | n.264G>A | non_coding_transcript_exon_variant | 1/3 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00160 AC: 243AN: 152234Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000380 AC: 95AN: 250064Hom.: 1 AF XY: 0.000288 AC XY: 39AN XY: 135434
GnomAD4 exome AF: 0.000186 AC: 271AN: 1459986Hom.: 2 Cov.: 32 AF XY: 0.000164 AC XY: 119AN XY: 726298
GnomAD4 genome AF: 0.00159 AC: 243AN: 152352Hom.: 1 Cov.: 33 AF XY: 0.00141 AC XY: 105AN XY: 74502
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 13, 2024 | The c.80G>A (p.G27E) alteration is located in exon 2 (coding exon 2) of the SLC30A2 gene. This alteration results from a G to A substitution at nucleotide position 80, causing the glycine (G) at amino acid position 27 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at